Search research articles
Contact Us
Filters
Showing results (11-20 of 92) with videos related to
Page
of 10
Sort By:
Neurology
|
June 1, 1996
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
A F Carpentier, A M Bonnet, M Vidailhet, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movements
Y Agid, A M Bonnet, M Ruberg, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
May 3, 2011
[Anaesthesia and Parkinson's disease]
V Chhor, C Karachi, A-M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1989
Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease
E Pourcher, A M Bonnet, J Kefalos, et al.
Neurology
|
August 1, 1984
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease
A M Bonnet, M Esteguy, J Guimaraes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
M Vidailhet, A M Bonnet, R Marconi, et al.
Revue Neurologique
|
January 1, 1985
[The L-dopa test in Parkinson's disease]
M Esteguy, A M Bonnet, J Kefalos, et al.
Lancet (London, England)
|
August 25, 1999
Blood vessels change in the mesencephalon of patients with Parkinson's disease
B A Faucheux, A M Bonnet, Y Agid, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine
A M Bonnet, I Serre, R Marconi, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 92) with videos related to
Sort By:
Page
of 10
Neurology
|
June 1, 1996
Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
A F Carpentier, A M Bonnet, M Vidailhet, et al.
Psychopharmacology. Supplementum
|
January 1, 1985
Pathophysiology of L-dopa-induced abnormal involuntary movements
Y Agid, A M Bonnet, M Ruberg, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
May 3, 2011
[Anaesthesia and Parkinson's disease]
V Chhor, C Karachi, A-M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1989
Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease
E Pourcher, A M Bonnet, J Kefalos, et al.
Neurology
|
August 1, 1984
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease
A M Bonnet, M Esteguy, J Guimaraes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
M Vidailhet, A M Bonnet, R Marconi, et al.
Revue Neurologique
|
January 1, 1985
[The L-dopa test in Parkinson's disease]
M Esteguy, A M Bonnet, J Kefalos, et al.
Lancet (London, England)
|
August 25, 1999
Blood vessels change in the mesencephalon of patients with Parkinson's disease
B A Faucheux, A M Bonnet, Y Agid, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine
A M Bonnet, I Serre, R Marconi, et al.
Page
of 10